168 related articles for article (PubMed ID: 36472871)
21. Trends in Tobacco Use Among Adolescents by Grade, Sex, and Race, 1991-2019.
Meza R; Jimenez-Mendoza E; Levy DT
JAMA Netw Open; 2020 Dec; 3(12):e2027465. PubMed ID: 33263760
[TBL] [Abstract][Full Text] [Related]
22. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
23. Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults.
Khatana SAM; Venkataramani AS; Nathan AS; Dayoub EJ; Eberly LA; Kazi DS; Yeh RW; Mitra N; Subramanian SV; Groeneveld PW
JAMA; 2021 Feb; 325(5):445-453. PubMed ID: 33528535
[TBL] [Abstract][Full Text] [Related]
24. U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer.
Ribeiro TB; Ribeiro A; Rodrigues LO; Harada G; Nobre MRC
Int J Technol Assess Health Care; 2020; 36(1):20-28. PubMed ID: 31775939
[TBL] [Abstract][Full Text] [Related]
25. An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate.
Chen EY; Raghunathan V; Prasad V
JAMA Intern Med; 2019 Jul; 179(7):915-921. PubMed ID: 31135822
[TBL] [Abstract][Full Text] [Related]
26. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
Sacks LV; Shamsuddin HH; Yasinskaya YI; Bouri K; Lanthier ML; Sherman RE
JAMA; 2014 Jan 22-29; 311(4):378-84. PubMed ID: 24449316
[TBL] [Abstract][Full Text] [Related]
27. Oropharyngeal squamous cell carcinoma incidence and mortality trends in the United States, 1973-2013.
Megwalu UC; Sirjani D; Devine EE
Laryngoscope; 2018 Jul; 128(7):1582-1588. PubMed ID: 29086431
[TBL] [Abstract][Full Text] [Related]
28. Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action.
Olivier T; Haslam A; Prasad V
JAMA Netw Open; 2021 Dec; 4(12):e2138793. PubMed ID: 34905002
[TBL] [Abstract][Full Text] [Related]
29. Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991-2015.
Dulskas A; Cerkauskaite D; Vincerževskiene I; Urbonas V
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920754
[TBL] [Abstract][Full Text] [Related]
30. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
31. Trends in Infective Endocarditis in California and New York State, 1998-2013.
Toyoda N; Chikwe J; Itagaki S; Gelijns AC; Adams DH; Egorova NN
JAMA; 2017 Apr; 317(16):1652-1660. PubMed ID: 28444279
[TBL] [Abstract][Full Text] [Related]
32. Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration's recommendation: a cross-sectional analysis in New York.
Kim EJ; Coppa K; Hirsch JS; Abrahams S; Johnson J; Lesser M; Davidson KW; Conigliaro J; ;
BMJ Open; 2021 Feb; 11(2):e042965. PubMed ID: 33558355
[TBL] [Abstract][Full Text] [Related]
33. Comparison of All-Cause Mortality Rates and Inequities Between Black and White Populations Across the 30 Most Populous US Cities.
Benjamins MR; Silva A; Saiyed NS; De Maio FG
JAMA Netw Open; 2021 Jan; 4(1):e2032086. PubMed ID: 33471116
[TBL] [Abstract][Full Text] [Related]
34. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2020 Jan; 323(2):164-176. PubMed ID: 31935033
[TBL] [Abstract][Full Text] [Related]
35. Trends in Melanoma Mortality in Brazil: A Registry-Based Study.
Nader Marta G; Munhoz RR; Teixeira MP; Waldvogel BC; Pires de Camargo V; Feher O; Sanches JA
JCO Glob Oncol; 2020 Nov; 6():1766-1771. PubMed ID: 33201742
[TBL] [Abstract][Full Text] [Related]
36. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.
Jemal A; Saraiya M; Patel P; Cherala SS; Barnholtz-Sloan J; Kim J; Wiggins CL; Wingo PA
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S17-25.e1-3. PubMed ID: 22018063
[TBL] [Abstract][Full Text] [Related]
37. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
[TBL] [Abstract][Full Text] [Related]
38. Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era.
Lamba N; Ott PA; Iorgulescu JB
JAMA Netw Open; 2022 Aug; 5(8):e2225459. PubMed ID: 36006646
[TBL] [Abstract][Full Text] [Related]
39. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
